These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 21069942)

  • 1. [Translational research of molecular targeting drug for liver cancer].
    Tanaka S; Ui S
    Gan To Kagaku Ryoho; 2010 Oct; 37(10):1874-7. PubMed ID: 21069942
    [No Abstract]   [Full Text] [Related]  

  • 2. Searching for biological markers of molecular targeting treatment of liver cancer.
    Arao T; Kudo M; Nishio K
    Gan To Kagaku Ryoho; 2010 Oct; 37(10):1879-82. PubMed ID: 21069943
    [No Abstract]   [Full Text] [Related]  

  • 3. Targeting vessels to treat hepatocellular carcinoma.
    Romanque P; Piguet AC; Dufour JF
    Clin Sci (Lond); 2008 Apr; 114(7):467-77. PubMed ID: 18302534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now.
    Pang RW; Poon RT
    Oncology; 2007; 72 Suppl 1():30-44. PubMed ID: 18087180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Liver, pancreas, biliary tract cancer-basic and clinical researches for molecular targeting drug of liver cancer-].
    Ui S
    Gan To Kagaku Ryoho; 2010 Oct; 37(10):1872-3. PubMed ID: 21046843
    [No Abstract]   [Full Text] [Related]  

  • 6. Selective induction of tumor ischemia: development of vascular targeting agents for cancer therapy.
    Chaplin DJ; Hill SA
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1381-4. PubMed ID: 12498016
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of sorafenib, molecular targeting drug, for advanced hepatocellular carcinoma.
    Kuzuya T; Tsuchiya K; Izumi N
    Gan To Kagaku Ryoho; 2010 Oct; 37(10):1883-86. PubMed ID: 21069944
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current advances in molecular targeted therapy of primary hepatocellular carcinoma].
    Yu L; Dai Z; Zhou J; Fan J
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):475-7. PubMed ID: 19567036
    [No Abstract]   [Full Text] [Related]  

  • 9. Current problems with systemic treatment of advanced hepatocellular cancer.
    He AR; Soe K; El Zouhairi M
    Curr Probl Cancer; 2010; 34(2):131-49. PubMed ID: 20417353
    [No Abstract]   [Full Text] [Related]  

  • 10. [Molecular targeting therapy for gynecologic cancer].
    Hatae M; Nakamura T; Onishi Y; Yamamoto F
    Gan To Kagaku Ryoho; 2008 Feb; 35(2):233-237. PubMed ID: 18372513
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeted therapy of hepatocellular cancer.
    Wysocki PJ
    Expert Opin Investig Drugs; 2010 Feb; 19(2):265-74. PubMed ID: 20074016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic targeting of the tumor vasculature.
    Tozer GM; Bicknell R
    Semin Radiat Oncol; 2004 Jul; 14(3):222-32. PubMed ID: 15254865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy for metastatic colorectal cancer to the liver: from chemotherapy to targeting therapy.
    Teng LS; Zheng Y; Zhang J
    Hepatobiliary Pancreat Dis Int; 2008 Dec; 7(6):569-70. PubMed ID: 19073400
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimizing the delivery of cancer drugs that block angiogenesis.
    Cao Y; Langer R
    Sci Transl Med; 2010 Jan; 2(15):15ps3. PubMed ID: 20371469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms and therapeutic development of angiogenesis inhibitors.
    Cao Y
    Adv Cancer Res; 2008; 100():113-31. PubMed ID: 18620094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis: the unifying concept in cancer?
    Saphir A
    J Natl Cancer Inst; 1997 Nov; 89(22):1658-9. PubMed ID: 9390530
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnosis of liver cancer and therapy].
    Ui S; Tanaka S; Ito K; Nakamura N; Kudo A; Noguchi N
    Gan To Kagaku Ryoho; 2008 Oct; 35(10):1676-80. PubMed ID: 18975455
    [No Abstract]   [Full Text] [Related]  

  • 18. [Importance of thalidomide in the treatment of cancer].
    Bay JO; Tournilhac O
    Bull Cancer; 2000 Apr; 87(4):301-2. PubMed ID: 10858046
    [No Abstract]   [Full Text] [Related]  

  • 19. Active targeting schemes for nanoparticle systems in cancer therapeutics.
    Byrne JD; Betancourt T; Brannon-Peppas L
    Adv Drug Deliv Rev; 2008 Dec; 60(15):1615-26. PubMed ID: 18840489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fight against cancer: the next round.
    Doherty M
    Drug Discov Today; 2004 Nov; 9(22):947-8. PubMed ID: 15539135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.